Xianghuo He

20.2k total citations · 4 hit papers
206 papers, 14.2k citations indexed

About

Xianghuo He is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xianghuo He has authored 206 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Molecular Biology, 106 papers in Cancer Research and 26 papers in Oncology. Recurrent topics in Xianghuo He's work include RNA modifications and cancer (62 papers), Cancer-related molecular mechanisms research (55 papers) and MicroRNA in disease regulation (52 papers). Xianghuo He is often cited by papers focused on RNA modifications and cancer (62 papers), Cancer-related molecular mechanisms research (55 papers) and MicroRNA in disease regulation (52 papers). Xianghuo He collaborates with scholars based in China, United States and Hong Kong. Xianghuo He's co-authors include Shenglin Huang, Jianren Gu, Weijie Guo, Qiupeng Zheng, Linhui Liang, Chunyang Bao, Shuyi Li, Yingjun Zhao, Jinjun Li and Ming Yao and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Xianghuo He

201 papers receiving 14.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis

2015 1.8k citations Qiupeng Zheng, Weijie Guo et al. profile →
Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs

2016 1.6k citations Qiupeng Zheng, Weijie Guo et al. Nature Communications profile →
Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer

2016 580 citations Qiupeng Zheng, Biqiang Zheng et al. Cancer Letters profile →
exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes

2017 422 citations Shengli Li, Yuchen Li et al. profile →

Peers

Countries citing papers authored by Xianghuo He

Since Specialization

Citations

This map shows the geographic impact of Xianghuo He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianghuo He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianghuo He more than expected).

Fields of papers citing papers by Xianghuo He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianghuo He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianghuo He. The network helps show where Xianghuo He may publish in the future.

Co-authorship network of co-authors of Xianghuo He

This figure shows the co-authorship network connecting the top 25 collaborators of Xianghuo He. A scholar is included among the top collaborators of Xianghuo He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianghuo He. Xianghuo He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial 2024 ·Signal Transduction and Targeted Therapy ·(unknown), (unknown), (unknown), Pengfei Chen, Mengfan Zhang, Tengfei Li, Dechao Jiao, Yanliang Li, Xianghuo He, Xing Cheng, Haibo Wang, (unknown), (unknown), Shixi Zhang, Qıang Zhang, Peixin Zhu, Yu Chang, (unknown), Jianzhuang Ren, (unknown)	4
2	Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancer 2024 ·Cancer Letters ·Yizhe Liu, Qili Shi, Yanfang Liu, Xinrong Li, Zhen Wang, Shenglin Huang, Zhiao Chen, Xianghuo He	3
3	Glucose‐induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinoma 2024 ·Clinical and Translational Medicine ·Yanfang Liu, (unknown), Qili Shi, Bing Chen, Wenying Qiu, Yizhe Liu, (unknown), Xianghuo He	2
4	Girdin Promotes Tumorigenesis and Chemoresistance in Lung Adenocarcinoma by Interacting with PKM2 2022 ·Cancers ·(unknown), Desong Yang, (unknown), Can Lu, Xianghuo He, Songming Chen, (unknown), (unknown), (unknown), Atsushi Enomoto, Masahide Takahashi, Liang Weng	10
5	Application of third-generation sequencing in cancer research 2021 ·SHILAP Revista de lepidopterología ·Zhiao Chen, Xianghuo He	10
6	HMGA2 Polymorphisms and Hepatoblastoma Susceptibility: A Five-Center Case-Control Study 2020 ·SHILAP Revista de lepidopterología ·Li L, Zhenjian Zhuo, Yang Zhang, Jiang Zhu, Xianghuo He, Jiän Zhang, Xin Yu, Jianxing He, Tao Zhang	4
7	LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α 2020 ·Oncogene ·Linguo Xu, Lin Huan, Tianan Guo, Yangjun Wu, Yanfang Liu, Qifeng Wang, Shenglin Huang, Ye Xu, Linhui Liang, Xianghuo He	69
8	Splicing Regulator p54nrb/Non–POU Domain–Containing Octamer‐Binding Protein Enhances Carcinogenesis Through Oncogenic Isoform Switch of MYC Box–Dependent Interacting Protein 1 in Hepatocellular Carcinoma 2019 ·Hepatology ·Zhixiang Hu, Liangqing Dong, Shengli Li, Zhe Li, (unknown), Yuchen Li, Jie Ding, Zhiao Chen, Yangjun Wu, Zhen Wang, Shenglin Huang, Qiang Gao, Yingjun Zhao, Xianghuo He	50
9	Tumor‐Specific Transcripts Are Frequently Expressed in Hepatocellular Carcinoma With Clinical Implication and Potential Function 2019 ·Hepatology ·Qiupeng Zheng, Jingjing Zhao, Hui Yu, Huajie Zong, Xigan He, Yiming Zhao, Yan Li, Yu Wang, (unknown), Yuchen Li, Bing Chen, Weijie Guo, Yilin Wang, Zhiao Chen, Yingjun Zhao, Lu Wang, Xianghuo He, Shenglin Huang	18
10	The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma 2018 ·Nature Communications ·Zhe Li, Jiwei Zhang, Xinyang Liu, Shengli Li, Qifeng Wang, Di Chen, Zhixiang Hu, Tao Yu, Jie Ding, Jinjun Li, Ming Yao, Jia Fan, Shenglin Huang, Qiang Gao, Yingjun Zhao, Xianghuo He	170
11	Transcriptome‐Wide Analysis Reveals the Landscape of Aberrant Alternative Splicing Events in Liver Cancer 2018 ·Hepatology ·Shengli Li, Zhixiang Hu, Yingjun Zhao, Shenglin Huang, Xianghuo He	92
12	MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway 2017 ·Cancer Research ·Tao Yu, Yingjun Zhao, Zhixiang Hu, Jing Li, Dandan Chu, Jiwei Zhang, Zhe Li, Bing Chen, Xiao Zhang, Hongyu Pan, Shengli Li, Hechun Lin, Lei Liu, Mingxia Yan, Xianghuo He, Ming Yao	142
13	Transcriptomic analyses of RNA‐binding proteins reveal eIF3c promotes cell proliferation in hepatocellular carcinoma 2017 ·Cancer Science ·(unknown), Shengli Li, Di Chen, Bing Chen, Tao Yu, Fangyu Zhao, Qifeng Wang, Ming Yao, Shenglin Huang, Zhiao Chen, Xianghuo He	29
14	Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin‐6/STAT3 signaling pathway 2017 ·Hepatology ·Jiwei Zhang, Zhe Li, Longzi Liu, Qifeng Wang, Shengli Li, Di Chen, Zhixiang Hu, Tao Yu, Jie Ding, Jinjun Li, Ming Yao, Shenglin Huang, Yingjun Zhao, Xianghuo He	178
15	TRIM35 Interacts with pyruvate kinase isoform M2 to suppress the Warburg effect and tumorigenicity in hepatocellular carcinoma 2014 ·Oncogene ·Zhiao Chen, Zhijun Wang, Weijie Guo, Zhao Zhang, Fangyu Zhao, Yingjun Zhao, Deshui Jia, Jie Ding, (unknown), Ming Yao, Xianghuo He	73
16	MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma 2013 ·Clinical Cancer Research ·Qifeng Wang, Zhaohui Huang, Weijie Guo, Shujuan Ni, Xiuying Xiao, Lisha Wang, Dan Huang, Cong Tan, Qinghua Xu, Ruopeng Zha, Jiwei Zhang, Weiqi Sheng, Xianghuo He, Xiang Du	63
17	CXCR6 Upregulation Contributes to a Proinflammatory Tumor Microenvironment That Drives Metastasis and Poor Patient Outcomes in Hepatocellular Carcinoma 2012 ·Cancer Research ·Qiang Gao, Yingjun Zhao, Xiaoying Wang, Shuang–Jian Qiu, Yongyong Shi, Jian Sun, Yong Yi, Jie-Yi Shi, Guo‐Ming Shi, Zhen‐Bin Ding, Yongsheng Xiao, Zhonghua Zhao, Jian Zhou, Xianghuo He, Jia Fan	136
18	GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma 2012 ·SHILAP Revista de lepidopterología ·Jian Yao, Linhui Liang, Yu Zhang, Jie Ding, Qi Tian, Jinjun Li, Xianghuo He	5
19	MicroRNA-148a Suppresses Tumor Cell Invasion and Metastasis by Downregulating ROCK1 in Gastric Cancer 2011 ·Clinical Cancer Research ·Biqiang Zheng, Linhui Liang, Chunmeng Wang, Shenglin Huang, Xi Cao, Ruopeng Zha, Li Liu, Deshui Jia, Qi Tian, Jianghong Wu, (unknown), Qifeng Wang, Ziwen Long, Ye Zhou, Chunyan Du, Xianghuo He, Yingqiang Shi	230
20	MicroRNA-95 Promotes Cell Proliferation and Targets Sorting Nexin 1 in Human Colorectal Carcinoma 2011 ·Cancer Research ·Zhaohui Huang, Shenglin Huang, Qifeng Wang, Linhui Liang, Shujuan Ni, Lisha Wang, Weiqi Sheng, Xianghuo He, Xiang Du	114

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact